VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
MBIO
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
MBIOMustang Bio, Inc.
$0.70$5M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksMBIOQuarterly Financials

Mustang Bio, Inc. (MBIO) Quarterly Financials

120+ quarters historyFree accessUpdated daily

Mustang Bio, Inc. (MBIO) quarterly income statement — complete revenue, gross profit & net income history

MBIO Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21Q2'21
Sales/Revenue00000000000000000000
Revenue Growth %--------------------
Cost of Goods Sold000041K000696K00000000000
COGS % of Revenue--------------------
Gross Profit0000-41K000-696K00000000000
Gross Margin %--------------------
Gross Profit Growth %100%---94.11%---------------
Operating Expenses1.06M670K624K885K212K1.02M1.46M8.54M4.54M8.74M10.31M13.89M16.32M19.43M18.85M18.24M19.64M20.12M17.08M14.44M
OpEx % of Revenue--------------------
Selling, General & Admin880K987K957K787K1.22M-223K1.4M1.53M1.43M2.18M2.13M3.06M2.32M2.4M3.39M3.08M3.35M2.65M2.36M2.54M
SG&A % of Revenue--------------------
Research & Development178K-317K333K98K964K197K57K4.36M3.52M6.68M9.53M10.84M14M17.04M15.46M15.16M16.29M17.47M14.71M11.9M
R&D % of Revenue--------------------
Other Operating Expenses00-666K0-1000K1000K01000K-411K-115K-1000K000000000
Operating Income-1.06M-670K-624K-885K-253K-1.02M-1.46M-8.54M-5.23M-8.74M-10.31M-13.89M-16.32M-19.43M-18.85M-18.24M-19.64M-20.12M-17.08M-14.44M
Operating Margin %--------------------
Operating Income Growth %-318.18%34.12%57.17%89.64%95.16%88.37%85.86%38.52%67.95%55.02%45.32%23.85%16.89%3.41%-10.37%-26.32%-30.16%2.98%-63.78%-2.26%
EBITDA-1.06M-670K-468K-885K-212K-942K-1.41M-8.54M-4.54M-8.38M-9.94M-13.25M-15.46M-18.6M-18.03M-17.54M-18.96M-19.43M-16.46M-13.93M
EBITDA Margin %--------------------
EBITDA Growth %-399.06%28.87%66.71%89.64%95.33%88.76%85.86%35.57%70.67%54.95%44.87%24.44%18.44%4.27%-9.5%-25.95%-29.88%4.1%-65.03%-1.88%
D&A (Non-Cash Add-back)000041K75K51K1K696K363K367K637K858K834K819K699K679K692K612K512K
EBIT-1.06M-670K-468K-885K-153K-951K-1.41M-5.89M-5.19M-11.41M-10.05M-16.1M-15.52M-18.47M-17.96M-18.16M-19.57M-20.05M-17M-14.36M
Net Interest Income103K132K156K123K100K65K47K27K40K123K111K22K-723K-837K-818K-858K-157K70K72K81K
Interest Income103K132K156K123K100K66K48K29K41K123K115K159K453K323K216K77K73K74K75K85K
Interest Expense000001K1K2K1K04K137K1.18M1.16M1.03M935K230K4K3K4K
Other Income/Expense103K132K156K123K100K65K47K341K40K125K249K-2.34M-372K-202K-149K-858K-157K70K72K81K
Pretax Income-955K-538K-468K-762K-153K-952K-1.41M-8.2M-5.19M-8.62M-10.06M-16.23M-16.69M-19.63M-19M-19.1M-19.8M-20.05M-17M-14.36M
Pretax Margin %--------------------
Income Tax00000000000000000000
Effective Tax Rate %0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%
Net Income-955K-538K-468K-762K-153K-952K-1.41M-8.2M-5.19M-8.62M-10.06M-16.23M-16.69M-19.63M-19M-19.1M-19.8M-20.05M-17M-14.36M
Net Margin %--------------------
Net Income Growth %-524.18%43.49%66.81%90.71%97.05%88.95%85.98%49.5%68.9%56.12%47.05%15%15.67%2.07%-11.71%-33.01%-32.35%2.71%-31.29%1.64%
Net Income (Continuing)-955K-538K-468K-762K-153K-952K-1.41M-8.2M-5.19M-8.62M-10.06M-16.23M-16.69M-19.63M-19M-19.1M-19.8M-20.05M-17M-14.36M
Discontinued Operations00000000000000000000
Minority Interest00000000000000000000
EPS (Diluted)-0.14-0.07-0.08-0.13-0.05-0.95-0.16-0.94-0.46-0.93-1.23-2.00-2.25-2.91-2.42-2.50-3.06-3.42-2.80-2.46
EPS Growth %-180%92.24%53.13%86.17%89.13%-2.15%86.99%53%79.56%68.04%49.17%20%26.47%14.91%13.57%-1.63%-9.68%41.84%17.4%49.38%
EPS (Basic)-0.14-0.07-0.08-0.13-0.05-0.95-0.16-0.94-0.46-0.93-1.23-2.00-2.25-2.91-2.42-2.50-3.06-3.42-2.80-2.46
Diluted Shares Outstanding6.73M7.3M6.24M5.98M5.72M8.69M8.69M8.69M11.25M9.22M8.17M8.13M8.09M7.16M7.85M7.65M6.53M5.86M6.08M5.84M
Basic Shares Outstanding6.73M7.3M6.24M5.98M5.72M8.69M8.69M8.69M11.25M9.22M8.17M8.13M8.09M7.16M7.85M7.65M6.53M5.86M6.08M5.84M
Dividend Payout Ratio--------------------